Below are the most recent publications written about "Antibody Formation" by people in Profiles.
-
Lal D, Song L, Brar T, Cope EK, Keim P, Williams S, Chung Y, Murugan V, LaBaer J, Magee DM. Antibody responses to the host microbiome in chronic rhinosinusitis. Int Forum Allergy Rhinol. 2023 08; 13(8):1503-1510.
-
Tassi Yunga S, Siriwardhana C, Fouda GG, Bobbili N, Sama G, Chen JJ, Leke RFG, Taylor DW. Characterization of the primary antibody response to Plasmodium falciparum antigens in infants living in a malaria-endemic area. Malar J. 2022 Nov 19; 21(1):346.
-
Schuettenberg A, Pi?a A, Metrailer M, Pel?ez-S?nchez RG, Agudelo-Fl?rez P, Lopez J?, Ryle L, Monroy FP, Altin JA, Ladner JT. Highly Multiplexed Serology for Nonhuman Mammals. Microbiol Spectr. 2022 10 26; 10(5):e0287322.
-
Elko EA, Nelson GA, Mead HL, Kelley EJ, Carvalho ST, Sarbo NG, Harms CE, Le Verche V, Cardoso AA, Ely JL, Boyle AS, Pi?a A, Henson SN, Rahee F, Keim PS, Celona KR, Yi J, Settles EW, Bota DA, Yu GC, Morris SR, Zaia JA, Ladner JT, Altin JA. COVID-19 vaccination elicits an evolving, cross-reactive antibody response to epitopes conserved with endemic coronavirus spike proteins. Cell Rep. 2022 07 05; 40(1):111022.
-
To A, Wong TAS, Lieberman MM, Thompson K, Ball AH, Pessaint L, Greenhouse J, Daham N, Cook A, Narvaez B, Flinchbaugh Z, Van Ry A, Yalley-Ogunro J, Andersen Elyard H, Lai CY, Donini O, Lehrer AT. A Recombinant Subunit Vaccine Induces a Potent, Broadly Neutralizing, and Durable Antibody Response in Macaques against the SARS-CoV-2 P.1 (Gamma) Variant. ACS Infect Dis. 2022 04 08; 8(4):825-840.
-
Harris BHL, Zuhair M, Di Giovannantonio M, Rosadas C, Khan M, Short CE, Thaventhiran T, Quinlan R, Taylor A, Calvez R, Taylor GP, Tedder RS, McClure MO, Fertleman M. Asymptomatic Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection in a Rehabilitation Facility: Evolution of the Presence of Nasopharyngeal SARS-CoV-2 and Serological Antibody Responses. J Infect Dis. 2021 02 03; 223(2):192-196.
-
Lima MP, Costa LE, Lage DP, Dias DS, Ribeiro PAF, Machado AS, Ramos FF, Salles BCS, Fagundes MI, Carvalho GB, Franklin ML, Ch?vez-Fumagalli MA, Machado-de-?vila RA, Menezes-Souza D, Duarte MC, Teixeira AL, Gon?alves DU, Coelho EAF. Diagnostic application of recombinant Leishmania proteins and evaluation of their in vitro immunogenicity after stimulation of immune cells collected from tegumentary leishmaniasis patients and healthy individuals. Cell Immunol. 2018 12; 334:61-69.
-
Loomis KH, Lindsay KE, Zurla C, Bhosle SM, Vanover DA, Blanchard EL, Kirschman JL, Bellamkonda RV, Santangelo PJ. In Vitro Transcribed mRNA Vaccines with Programmable Stimulation of Innate Immunity. Bioconjug Chem. 2018 09 19; 29(9):3072-3083.
-
Ramos-Ben?tez MJ, Lopez-Cruz LM, Aguayo V, Ruiz-Jimenez C, Espino AM. Cell-free expression, purification and immunoreactivity assessment of recombinant Fasciola hepatica saposin-like protein-2. Mol Biol Rep. 2018 Oct; 45(5):1551-1556.
-
Ing M, Hew BE, Fritzinger DC, Delignat S, Lacroix-Desmazes S, Vogel CW, Rayes J. Absence of a neutralizing antibody response to humanized cobra venom factor in mice. Mol Immunol. 2018 05; 97:1-7.